• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ESSENTIAL MEDICAL, INC. MANTA 18F; VASCULAR CLOSURE DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ESSENTIAL MEDICAL, INC. MANTA 18F; VASCULAR CLOSURE DEVICE Back to Search Results
Catalog Number 2115
Medical Device Problem Code Obstruction of Flow (2423)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 04/30/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
(b)(4).
 
Event or Problem Description
It was reported that: "tavr case.Physician got access with mik and ultrasound.Puff of contrast showed he was in a dissection plane.Removed mik, held pressure and re-stuck a second time with mik and ultrasound.Pre femoral angio was in true lumen, proceeded with tavr case.No issues advancing sheaths.When the valve entered through e-sheath, patient became irritable and was in pain.Continued with the tavr procedure.Physician was concerned about the dissection from the initial stick, so he took an angio with the sheath pulled back to the femoral.Sheath was occlusive.Physician removed e-sheath and closed with manta.When physician took the angio post manta, the vessel was occluded from iliac to distal to the manta closure.Physician consulted vascular surgery.Cut down was performed and the manta device was removed in its entirety.The patient was stable post the procedure.".
 
Additional Manufacturer Narrative
(b)(4).Complaint verification testing could not be performed as no sample was returned for analysis.The details of the complaint were reviewed.It is likely that the dissection or vessel factors caused by the initial stick and/or the e-sheath could have led to occlusion.A device history record review was performed, and no relevant findings were identified.Without the device to evaluate, the complaint could not be confirmed, and the probable cause could not be determined from the available information.Teleflex will continue to monitor and trend for reports of this nature.
 
Event or Problem Description
It was reported that: "tavr case.Physician got access with mik and ultrasound.Puff of contrast showed he was in a dissection plane.Removed mik, held pressure and re-stuck a second time with mik and ultrasound.Pre femoral angio was in true lumen, proceeded with tavr case.No issues advancing sheaths.When the valve entered through e-sheath, patient became irritable and was in pain.Continued with the tavr procedure.Physician was concerned about the dissection from the initial stick, so he took an angio with the sheath pulled back to the femoral.Sheath was occlusive.Physician removed e-sheath and closed with manta.When physician took the angio post manta, the vessel was occluded from iliac to distal to the manta closure.Physician consulted vascular surgery.Cut down was performed and the manta device was removed in its entirety.The patient was stable post the procedure.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MANTA 18F
Common Device Name
VASCULAR CLOSURE DEVICE
Manufacturer (Section D)
ESSENTIAL MEDICAL, INC.
exton
Manufacturer (Section G)
ESSENTIAL MEDICAL, INC.
260 sierra drive
exton
Manufacturer Contact
kevin don bosco
3015 carrington mill blvd
morrisville, NC 27560
MDR Report Key22042511
Report Number3010252479-2025-00051
Device Sequence Number8781899
Product Code MGB
UDI-Device Identifier00856279007062
UDI-Public(01)00856279007062(11)240515(17)251115(10)73E2400582(21)
Combination Product (Y/N)N
Initial Reporter StateLA
Initial Reporter CountryUS
PMA/510(K) Number
P180025
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,User Facility,Company Representative
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 04/30/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date11/15/2025
Device Catalogue Number2115
Device Lot Number73E2400582
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 04/30/2025
Supplement Date Received by Manufacturer06/19/2025
Initial Report FDA Received Date05/19/2025
Supplement Report FDA Received Date06/23/2025
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured05/15/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
NOT REPORTED; NOT REPORTED
Outcome Attributed to Adverse Event Required Intervention;
Patient Age76 YR
Patient SexUnknown
Patient Weight109 KG
-
-